BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 2228026)

  • 1. IL-5 enhances the in vitro adhesion of human eosinophils, but not neutrophils, in a leucocyte integrin (CD11/18)-dependent manner.
    Walsh GM; Hartnell A; Wardlaw AJ; Kurihara K; Sanderson CJ; Kay AB
    Immunology; 1990 Oct; 71(2):258-65. PubMed ID: 2228026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-5 enhances the in vitro adhesion of human eosinophils, but not neutrophils, in a leucocyte integrin (CD11/18)-dependent manner.
    Walsh GM; Wardlaw AJ; Hartnell A; Sanderson CJ; Kay AB
    Int Arch Allergy Appl Immunol; 1991; 94(1-4):174-8. PubMed ID: 1682271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human eosinophil, but not neutrophil, adherence to IL-1-stimulated human umbilical vascular endothelial cells is alpha 4 beta 1 (very late antigen-4) dependent.
    Walsh GM; Mermod JJ; Hartnell A; Kay AB; Wardlaw AJ
    J Immunol; 1991 May; 146(10):3419-23. PubMed ID: 1709195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the integrin and activation steps mediating human eosinophil and neutrophil adhesion to chronically inflamed airway endothelium.
    McNulty CA; Symon FA; Wardlaw AJ
    Am J Respir Cell Mol Biol; 1999 Jun; 20(6):1251-9. PubMed ID: 10340944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engagement of alpha4beta7 integrins by monoclonal antibodies or ligands enhances survival of human eosinophils in vitro.
    Meerschaert J; Vrtis RF; Shikama Y; Sedgwick JB; Busse WW; Mosher DF
    J Immunol; 1999 Dec; 163(11):6217-27. PubMed ID: 10570314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Granulocyte-macrophage-colony-stimulating factor differentially regulates neutrophil migration across IL-1-activated and nonactivated human endothelium.
    Yong KL; Linch DC
    J Immunol; 1993 Mar; 150(6):2449-56. PubMed ID: 7680693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ligation of members of the beta 1 or the beta 2 subfamilies of integrins by antibodies triggers eosinophil respiratory burst and spreading.
    Laudanna C; Melotti P; Bonizzato C; Piacentini G; Boner A; Serra MC; Berton G
    Immunology; 1993 Oct; 80(2):273-80. PubMed ID: 7903278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD11b/CD18 (Mac-1) is required for degranulation of human eosinophils induced by human recombinant granulocyte-macrophage colony-stimulating factor and platelet-activating factor.
    Horie S; Kita H
    J Immunol; 1994 Jun; 152(11):5457-67. PubMed ID: 7514638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon-gamma enhances human eosinophil effector functions induced by granulocyte-macrophage colony-stimulating factor or interleukin-5.
    Yamaguchi T; Kimura H; Kurabayashi M; Kozawa K; Kato M
    Immunol Lett; 2008 Jun; 118(1):88-95. PubMed ID: 18440651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulation of eosinophil adherence to human vascular endothelial cells in vitro by platelet-activating factor.
    Kimani G; Tonnesen MG; Henson PM
    J Immunol; 1988 May; 140(9):3161-6. PubMed ID: 3361129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms and regulation of polymorphonuclear leukocyte and eosinophil adherence to human airway epithelial cells.
    Jagels MA; Daffern PJ; Zuraw BL; Hugli TE
    Am J Respir Cell Mol Biol; 1999 Sep; 21(3):418-27. PubMed ID: 10460760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the adhesive interaction between purified human eosinophils and cultured vascular endothelial cells.
    Lamas AM; Mulroney CM; Schleimer RP
    J Immunol; 1988 Mar; 140(5):1500-5. PubMed ID: 3279115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new antihistamine levocetirizine inhibits eosinophil adhesion to vascular cell adhesion molecule-1 under flow conditions.
    Wu P; Mitchell S; Walsh GM
    Clin Exp Allergy; 2005 Aug; 35(8):1073-9. PubMed ID: 16120090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of conditioned medium from cultured human bronchial epithelial cells on eosinophil and neutrophil chemotaxis and adherence in vitro.
    Abdelaziz MM; Devalia JL; Khair OA; Calderon M; Sapsford RJ; Davies RJ
    Am J Respir Cell Mol Biol; 1995 Dec; 13(6):728-37. PubMed ID: 7576711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GM-CSF regulates human eosinophil responses to F-Met peptide and platelet activating factor.
    Tomioka K; MacGlashan DW; Lichtenstein LM; Bochner BS; Schleimer RP
    J Immunol; 1993 Nov; 151(9):4989-97. PubMed ID: 8409452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-4 controls the selective endothelium-driven transmigration of eosinophils from allergic individuals.
    Moser R; Fehr J; Bruijnzeel PL
    J Immunol; 1992 Aug; 149(4):1432-8. PubMed ID: 1354235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-3-induced up-regulation of CR3 expression on human eosinophils is inhibited by dexamethasone.
    Hartnell A; Kay AB; Wardlaw AJ
    Immunology; 1992 Dec; 77(4):488-93. PubMed ID: 1493920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eosinophil transendothelial migration induced by cytokines. II. Potentiation of eosinophil transendothelial migration by eosinophil-active cytokines.
    Ebisawa M; Liu MC; Yamada T; Kato M; Lichtenstein LM; Bochner BS; Schleimer RP
    J Immunol; 1994 May; 152(9):4590-6. PubMed ID: 8157972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of C3a and C5a-mediated stable adhesion of rolling eosinophils in postcapillary venules and transendothelial migration in vitro and in vivo.
    DiScipio RG; Daffern PJ; Jagels MA; Broide DH; Sriramarao P
    J Immunol; 1999 Jan; 162(2):1127-36. PubMed ID: 9916743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of transendothelial migration on eosinophil function.
    Yamamoto H; Sedgwick JB; Vrtis RF; Busse WW
    Am J Respir Cell Mol Biol; 2000 Sep; 23(3):379-88. PubMed ID: 10970830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.